Skip to main content
Signal8

Prasad Raju

SEC insider (Form 3/4/5 filer). CIK 0001968317. Chief Financial Officer at CRISPR Therapeutics AG (CRSP). 31 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in BOSTON, MA.

Companies Prasad Raju has filed insider reports for

  • CRISPR Therapeutics AG (CRSP): Officer, Chief Financial Officer
Prasad Raju profile photo

Prasad Raju

CIK: 0001968317

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (38.7%)

Position reduction

Option Exercises (M)8 (25.8%)

Derivative conversions

Awards (A)9 (29.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (6.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CRISPR Therapeutics AG logo
CRSP

CRISPR Therapeutics AG

Officer

Discretionary Trading P&L

Holdings

Transaction History (31 total)

  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Aug 7, 2026
    Gift
    Direct
    750 shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    May 29, 2026
    Award

    Restricted Stock Units

    Direct
    19.5K shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 23, 2026
    Sale
    Direct
    3.7K shares at avg. $46.78$173K
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 20, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    38.5K shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 20, 2026
    Award

    Restricted Stock Units

    Direct
    27.5K shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 20, 2026
    Exercise
    Direct
    6.3K shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 16, 2026
    Sale
    Direct
    4K shares at avg. $48.26$194K
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 16, 2026
    Sale
    Direct
    5.8K shares at avg. $48.26$282K
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 16, 2026
    Gift
    Direct
    750 shares-
  • CRISPR Therapeutics AG logo
    CRSP

    CRISPR Therapeutics AG

    Mar 14, 2026
    Exercise
    Direct
    6.9K shares-

1-10 of 31